Morgan Stanley Announces Q1 2025 Results

Morgan Stanley recently released its first-quarter financial results for 2025, demonstrating its performance amidst a difficult economic backdrop. The financial services firm reported consistent revenue growth, primarily fueled by its wealth management and investment banking divisions. Despite fluctuations in the global market, Morgan Stanley's diversified approach has enabled it to…

Tech Stocks Rally on Renewed Investor Confidence

Fueled by a resurgence in investor confidence, technology stocks are experiencing a broad rally. Gains from leading tech companies, particularly the "Magnificent Seven" including Tesla (NASDAQ:TSLA) and Nvidia (NASDAQ:NVDA), are pulling the sector upwards. Improved investor sentiment is a result of encouraging economic data and better-than-expected earnings reports. Tesla, an…

Japan Wi-Fi App Integrates Tourist Information from LIVE JAPAN for Enhanced International Visitor Experience

TOKYO, April 10, 2025 — NTT Broadband Platform, Inc. (NTTBP) has been offering the "Japan Wi-Fi auto-connect" smartphone app (Japan Wi-Fi) since December 2019. This app automatically connects users to free Wi-Fi hotspots available nationwide in locations such as local government facilities, public transport hubs, commercial buildings, and tourist attractions.…

Info-Tech Research Group’s New Report Reveals 2025’s Leading Conversational AI Platforms “`

A newly published 2025 Conversational AI Data Quadrant Report from Info-Tech Research Group has pinpointed the leading virtual assistant platforms. This determination is based on feedback from 471 verified users on Info-Tech's SoftwareReviews platform. The report assesses factors such as usability, feature range, vendor capabilities, and overall user contentment. TORONTO,…

IDEAYA Biosciences Advances Phase 1/2 Trial of IDE397 and Trodelvy® Combination Therapy for Urothelial Cancer with MTAP Deletion

Based on early safety and efficacy results, a Phase 1/2 study is expanding to assess IDE397, IDEAYA’s MAT2A inhibitor, combined with Gilead’s Trop-2 directed ADC, Trodelvy®, for urothelial cancer with MTAP-deletion. Approximately 26% of urothelial cancers are estimated to have MTAP-deletion. SOUTH SAN FRANCISCO, Calif., April 10, 2025 — IDEAYA…

Tariff Truce Lifts S&P 500

The S&P 500 marked its best day since 2008, boosted by the Trump administration's unexpected decision to put tariff hikes on hold. This action aimed to ease trade tensions between the U.S. and China, a major source of instability in global markets. Investors reacted positively, driving up stock prices across…